Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.96 USD | -1.48% | -6.85% | -0.58% |
May. 13 | Liquidia Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.58% | 914M | |
+30.77% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+14.79% | 239B | |
+9.84% | 210B | |
-7.36% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- LQDA Stock
- News Liquidia Corporation
- Transcript : Liquidia Corporation, Q4 2021 Earnings Call, Mar 17, 2022